Amakem has raised €18 million to go towards the development of highly potent kinase (ROCK) inhibitor AMA0076.
Articles
The KAMRA inlay (AcuFocus) is an effective, safe and reversible technique for the long-term surgical treatment of presbyopia.
Cycloisporine A (CSA) 1% eye drops could be an effective corticosteroid-sparing agent for treating symptomatic corneal subepithelial infiltrates (SEI) after adenoviral keraconjunctivitis (AK).
Conventional automated keratometry is better at measuring refractive outcomes after cataract surgery than pupil-based Scheimpflug keratometry.
Balancing risk in ophthalmic prescribing for wet AMD
Examining the role of SLT in the glaucoma treatment arsenal
Differences in nerve fibre layer (NFL) in the macular area can be easily detected using a modified optical coherence tomography (OCT) scanning technique.
Decreased tear levels of neuropeptide Y (NPY) and calcitonin gene?related peptide (CGRP) are linked to damaged tear function.
The spatial distribution and temporal profiles of corneal light scattering after corneal collagen crosslinking (CXL) are distinctive in keratoconus patients.
A combination of scleral buckling and vitrectomy produced better anatomical success rates and fewer operative procedures in surgery for primary retinal detachment patients.
Measuring ocular biometry in paediatric patients
Procedure using excimer laser, optimized prolate albation profile is a work in progress
Novel presbyopic treatment algorithm is part of the latest ablation planing software
ICR femto-incision technology simplifies surgery
The future of glaucoma medications and disease management
Diagnostic platform combines anterior surface topography, corneal tomography data
Better understanding the cornea pre- and post-refractive surgery
Intrastromal treatment optimal for patients with mild hyperopia, has strict indications
System's ability to induce flexibility in crystalline lens portends far-reaching effects on future
The best solution for minimizing induced ocular abberations after refractive surgery
As World Sight Day 2011 approaches we speak with Dr Gullapalli Nag Rao, founder of LV Prasad Eye Institute, on what it means, what has already been achieved and what we can do to continue to be part of the solution.
An investigation in the Journal of Cataract and Refractive Surgery strongly suggests the use of fortified antibiotic agents for prevention of vision loss in infectious keratitis patients.
Ner and intermediate vision improvement with a corneal impant
Macular oedema caused by both BRVO and CRVO responds to treatment
A round-up of the latest ophthalmic products
Rapid image acquisition and quantitative analysis are possible
Establishing the pattern of management of diffuse diabetic macular oedema in England
New ophthalmic company KalVista Pharmaceuticals has generated £8 million from series A contributed by Novo A/S and SV Life Sciences.
Abbott Medical Optics' Healon EndoCoat has received the European CE Mark of approval.
Luminous, a program created to develop the understanding of retinal vascular diseases, has enrolled its first patient this month.
Advertisement
Advertisement